Navigation Links
Endologix Announces First Clinical Implant of Ventana™ Stent Graft
Date:11/2/2010

stent graft procedure in the world.  Given our extensive experience with aortic aneurysmal disease and understanding the limitations of all commercially available endovascular devices, we believe that Ventana has the potential to address a significant unmet clinical need – a minimally invasive alternative for patients presenting with JAA or PAA. We look forward to participating in the Ventana clinical program and, following the completion of regulatory processes, having this important new technology available to treat our patients who otherwise have few options."

Dr. Clair added, "Unfortunately, many patients with JAA and PAA do not have much time to wait and need to be treated immediately to avoid aneurysm rupture.  The Ventana off-the-shelf design is unique in that it represents a potential minimally invasive solution for these difficult to treat aneurysms.  The device also leverages the good clinical results of the Powerlink design and anatomical fixation.  I am pleased with the progress that Endologix has made developing this device and look forward to initiating a U.S. multicenter clinical trial in 2011."

Beginning with the first clinical cases being performed with Ventana at Auckland City Hospital, Endologix will continue enrolling patients in international clinical studies in 2011. The results will be used to support international regulatory approvals to market the device, with international commercialization expected to commence in 2012.  Endologix also expects to submit an Investigational Device Exemption (IDE) to the United States Food and Drug Administration ("FDA") to support initiation of a prospective, multicenter, clinical trial for the treatment of JAA/PAA utilizing the Ventana fenestrated stent graft in 2011.

John McDermott, Endologix President and Chief Executive Officer said, "The successful first implant of the Ventana fenestrated stent graft is a major milestone for the Company.  Through o
'/>"/>

SOURCE Endologix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Endologix to Acquire Nellix
2. Endologix Reports 30% Third Quarter 2010 Revenue Growth
3. Endologix to Present at Oppenheimer 21st Annual Healthcare Conference
4. Endologix Announces Publication of Clinical Trial Results Supporting Anatomical Fixation with a Suprarenal Aortic Extension
5. Endologix to Report Third Quarter 2010 Financial Results on October 27, 2010
6. Endologix Receives CE Mark Approval for Expanded Line of Powerlink Products and PowerFit Aortic Extensions
7. Endologix Enters Development Agreement and Exclusive License for Balloon Expandable Stent Technology
8. Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement
9. Endologix Reports 47% Third Quarter 2009 Revenue Growth
10. Endologix to Report Third Quarter 2009 Financial Results on October 27, 2009
11. Endologix Responds to Alleged Patent Infringement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... and BRIDGEWATER, N.J. , ... REGN) and Sanofi US (EURONEXT: SAN and NYSE: SNY) ... organizations to launch Cholesterol Counts , an awareness ... cholesterol, their numbers, and the risks associated with high ... www. CholesterolCounts .com to take a brief ...
(Date:12/15/2014)... , Dec. 15, 2014   DaVita ... one of the nation,s largest and most innovative ... its business units, DaVita Clinical Research  (DCR) and  ... to further expand its extensive clinical research and ... kidney disease (CKD) and end-stage renal disease (ESRD), ...
(Date:12/13/2014)... , December 12, 2014 ... announced the addition of the  "Global Catheters ... Share, Global Trends, Company Profiles, Analysis, Segmentation ... to their offering.       (Logo: ... made up of medical grade material such ...
Breaking Medicine Technology:Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 2Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 3Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 4Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 5Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 6DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical Trials and Data Analytics Capabilities 2DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical Trials and Data Analytics Capabilities 3DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical Trials and Data Analytics Capabilities 4Global Catheters Market (Product Types and Geography) - Forecast to 2020 2Global Catheters Market (Product Types and Geography) - Forecast to 2020 3
... 2, 2011 Aoxing Pharmaceutical (NYSE Amex: ... company focusing on research, development, manufacturing and distribution ... operating subsidiary in China, Hebei Aoxing Pharmaceutical Group ... State Intellectual Property Office of The People,s Republic ...
... TARRYTOWN, N.Y., May 2, 2011 Regeneron Pharmaceuticals, Inc. (Nasdaq: ... of America Merrill Lynch 2011 Health Care Conference on Tuesday, ... Eastern Time).  The session may be accessed through the Company,s ...  An archived version of the presentation will be available after ...
Cached Medicine Technology:Aoxing Pharmaceutical Company Announces Issuance of Chinese Patent for Naloxone Sublingual Film 2Aoxing Pharmaceutical Company Announces Issuance of Chinese Patent for Naloxone Sublingual Film 3
(Date:12/17/2014)... Mass. (PRWEB) December 17, 2014 ... of Osteopathic Medicine (ACOM), which welcomed its inaugural ... Desktop Infrastructure (VDI) to seamlessly support bring your ... – and teaching – experience. The solution, comprised ... NetScaler , Dell server and storage infrastructure ...
(Date:12/17/2014)... (PRWEB) December 17, 2014 In its ... and its Argus Claim Review division have recently ... the most common ways savings are achieved on behalf ... attributes millions of dollars in savings to Argus each ... 2013. , As explained by Tom Doney, Cypress president ...
(Date:12/17/2014)... -- As gas prices rose in recent years, so ... In times of gas increases, more people start ... the researchers explained. They examined data gathered between ... number of motorcycle registrations in the United States and ... analysis revealed a strong association between rising gas prices ...
(Date:12/17/2014)... Dec. 16, 2014 (HealthDay News) -- Greater participation in ... study finds. Researchers followed kids in the nonprofit ... poor children in Los Angeles. Over two years, ... improvements in how the brain processes speech and reading, ... Also, the benefits of active participation in music classes ...
(Date:12/15/2014)... A recent survey found that the most ... skin health and beauty were: “Connections,” “climate,” “career” and ... and health advocate and radio host Sharon Kleyne agrees ... survey and the Four C’s.* Kleyne notes, however, that ... would benefit from paying attention to one’s daily fresh ...
Breaking Medicine News(10 mins):Health News:Alabama College of Osteopathic Medicine Deploys Desktop Virtualization Solution from Citrix, Dell and Unidesk 2Health News:Alabama College of Osteopathic Medicine Deploys Desktop Virtualization Solution from Citrix, Dell and Unidesk 3Health News:Out-of-Network & Medical Necessity Reviews among Top Ways TPA Identifies Significant Medical Claim Savings 2Health News:When Gas Prices Go Up, So Do Motorcycle Accidents, Study Finds 2Health News:Music Classes Boost Language Skills, Study Says 2Health News:Water and health advocate Sharon Kleyne adds a “W” for fresh water to “four C’s of skin care” 2Health News:Water and health advocate Sharon Kleyne adds a “W” for fresh water to “four C’s of skin care” 3
... Cutaneous leishmaniasis (CL) is a non-lethal disease but can ... be prevented with a rapid and accurate diagnosis and ... it is essential to establish the number of parasites ... before, during and after treatment in order to assess ...
... the life sciences, protocols provide individual sets ... experiments in their own laboratory. These documents ... of experiments that include the safety bias, ... standards for the experiment. , ...
... ... Partnership, PALO ALTO, ... VAR ) and BrainLAB AG are today announcing,that they have ... the most successful technologies,from both companies to offer superior noninvasive treatment ...
... 24 Sports,and nutritional product manufacturer, Natural Nutrition ... today that it will,launch in February 2008, its ... with a FUSION of rich and 100% REAL ... all natural nutrition bars are loaded with a,combination ...
... creates national integrated healthcare real estate company providing ... of services to hospitals and physicians ... of $55 Million, CHARLOTTE, N.C., Jan. 23 Cogdell ... a definitive merger agreement,to acquire 100 percent of the stock ...
... and its,participating vendors raised $137,500 during its 2007 ... awareness at the Barbara Ann Karmanos,Cancer Institute., ... of our vendors and purchases by our loyal,customers, ... to such an,important cause," said Rick Going, president ...
Cached Medicine News:Health News:Improved diagnosis of cutaneous leishmaniasis thanks to new techniques 2Health News:Springer launches Springer Protocols 2Health News:Varian and BrainLAB Announce Rapid Uptake of Powerful and Versatile Radiosurgery Platform 2Health News:Varian and BrainLAB Announce Rapid Uptake of Powerful and Versatile Radiosurgery Platform 3Health News:Natural Nutrition Launches All Natural FUSION Fruit Bar Line 2Health News:Cogdell Spencer Inc. Announces Merger with Marshall Erdman and Associates 2Health News:Cogdell Spencer Inc. Announces Merger with Marshall Erdman and Associates 3Health News:Cogdell Spencer Inc. Announces Merger with Marshall Erdman and Associates 4Health News:Cogdell Spencer Inc. Announces Merger with Marshall Erdman and Associates 5Health News:Kroger Pink Tag Campaign Raises $137,500 for Breast Cancer Research and Awareness at Karmanos Cancer Institute 2Health News:Kroger Pink Tag Campaign Raises $137,500 for Breast Cancer Research and Awareness at Karmanos Cancer Institute 3
... of a heartbeat. The bodys warmth beneath ... These vital signs are yours to guard, ... of Temperature Monitoring products helps you do ... to provide the most comfortable and precise ...
... The bodys warmth beneath drapes. The life-giving ... are yours to guard, measure, stabilize and ... products helps you do your job, giving ... most comfortable and precise management of your ...
... stabilization of the capsular bag in complicated ... Tension Ring has application in several different ... available for patients with pseudoexfoliation syndrome. Many ... tension ring, especially those in whom you ...
... The Smartlipo laser provokes the breaking ... adipose cells, transforming them into an ... eliminated in a natural manner. ... harmonious body shape in a short ...
Medicine Products: